M.Sc. from the Royal Institute of Technology (KTH), has vast experience as entrepreneur, CEO and director in the medical device and life science industry. In addition to Senzime, Siberg is the CEO of Coala Life AB, an e-health company active in digital monitoring of the heart and Chairman of Acacia Designs, a development and innovation company active in the field of anesthesia and patient monitoring. Siberg was previously CEO of Stille AB (publ.) and CMA Microdalysis AB, the pioneer in development, manufacturing and marketing of microdialysis solutions for drug development and patient monitoring.
Philip Siberg owned 732 989 shares in Senzime 19-03-31